All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
Mon 1984-11-05? to Fri 2025-02-21 |
YTD
Return |
TRR
Price |
||||
---|---|---|---|---|---|---|
GSK × |
+8.63%
2025-02-21 |
16.78 TRR
2025-02-21 |
||||
GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
Mon 1984-11-05? to Fri 2025-02-21 |
Overall
Return |
Exponential
Trendline |
||||
---|---|---|---|---|---|---|
GSK × |
+1,577.66%
+7.25%/yr |
+5.23%/yr
(R2=0.682) |
||||
GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
Mon 1984-11-05? to Fri 2025-02-21 |
Start
Value |
End
Value |
||||
---|---|---|---|---|---|---|
GSK × |
$10,000.00
1984-11-05 |
$167,765.57
2025-02-21 |
||||
GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
Year | GSK |
---|---|
2025 (YTD) | +8.63% |
2024 | −7.79% |
2023 | +6.15% |
2022 | −23.23% |
2021 | +18.32% |
2020 | −18.90% |
2019 | +26.26% |
2018 | +11.53% |
2017 | −5.06% |
2016 | −0.11% |
2015 | −1.07% |
2014 | −16.39% |
2013 | +26.91% |
2012 | −1.18% |
2011 | +18.95% |
2010 | −3.63% |
2009 | +16.08% |
2008 | −22.41% |
2007 | −4.75% |
2006 | +5.24% |
2005 | +6.15% |
2004 | +2.23% |
2003 | +26.29% |
2002 | −23.47% |
2001 | −11.04% |
2000 | +0.66% |
1999 | −20.10% |
1998 | +45.81% |
1997 | +53.16% |
1996 | +13.99% |
1995 | +41.63% |
1994 | +0.25% |
1993 | −12.83% |
1992 | −25.12% |
1991 | +92.92% |
1990 | +22.85% |
1989 | +32.49% |
1988 | +2.44% |
1987 | +15.34% |
1986 | +37.63% |
1985 | +68.49% |
1984 | −1.92% |
Mon 1984-11-05? to Fri 2025-02-21 |
Current
Drawdown |
Worst
Drawdown |
||||
---|---|---|---|---|---|---|
GSK × | −22.98% |
−60.55%
2009-03-09 |
||||
GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||